CRP and COVID-19: Although lung cancer progression has been reported to be associated with an elevated CRP level [25], the fact that 30 patients in this study had unresectable or advanced recurrent lung cancer, excluding a patient receiving adjuvant chemotherapy, and no significant differences in treatment lines were observed, suggests that the difference in CRP levels was strongly influenced by COVID-19.